These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 29117004
1. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. Castejón MA, Teus MA, Bolivar G, Paz-Moreno-Arrones J, Castaño B. J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004 [Abstract] [Full Text] [Related]
2. Phacotrabeculectomy using collagen matrix implant (Ologen® ) versus mitomycin C: a prospective randomized controlled trial. Wlaź A, Wilkos-Kuc A, Rozegnał-Madej A, Żarnowski T. Acta Ophthalmol; 2019 Sep; 97(6):e817-e826. PubMed ID: 30924600 [Abstract] [Full Text] [Related]
3. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. Johnson MS, Sarkisian SR. J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882 [Abstract] [Full Text] [Related]
4. Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. Narayanaswamy A, Perera SA, Htoon HM, Hoh ST, Seah SK, Wong TT, Aung T. Clin Exp Ophthalmol; 2013 Aug; 41(6):552-60. PubMed ID: 23279607 [Abstract] [Full Text] [Related]
5. Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C. Dada T, Kusumesh R, Bali SJ, Sharma S, Sobti A, Arora V, Panda A. J Glaucoma; 2013 Aug; 22(8):659-62. PubMed ID: 23059478 [Abstract] [Full Text] [Related]
6. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study. Salimi A, Kovalyuk N, Harasymowycz PJ. J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908 [Abstract] [Full Text] [Related]
7. Comparison of Surgical Outcomes Between Phacocanaloplasty and Phacotrabeculectomy at 12 Months' Follow-up: A Longitudinal Cohort Study. Schoenberg ED, Chaudhry AL, Chod R, Zurakowski D, Ayyala RS. J Glaucoma; 2015 Sep; 24(7):543-9. PubMed ID: 24240873 [Abstract] [Full Text] [Related]
8. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy. Sen M, Midha N, Sidhu T, Angmo D, Sihota R, Dada T. Ophthalmol Glaucoma; 2018 Sep; 1(2):88-98. PubMed ID: 32677614 [Abstract] [Full Text] [Related]
9. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up. Cillino S, Casuccio A, Di Pace F, Cagini C, Ferraro LL, Cillino G. BMC Ophthalmol; 2016 Mar 05; 16():24. PubMed ID: 26946419 [Abstract] [Full Text] [Related]
10. Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification. Paul C, Divya J, Kamal R, Paul A. Indian J Ophthalmol; 2022 Apr 05; 70(4):1248-1252. PubMed ID: 35326026 [Abstract] [Full Text] [Related]
11. Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes. Supawavej C, Nouri-Mahdavi K, Law SK, Caprioli J. J Glaucoma; 2013 Jan 05; 22(1):52-9. PubMed ID: 21623217 [Abstract] [Full Text] [Related]
12. Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. Murthy SK, Damji KF, Pan Y, Hodge WG. Can J Ophthalmol; 2006 Feb 05; 41(1):51-9. PubMed ID: 16462873 [Abstract] [Full Text] [Related]
13. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Tham CC, Kwong YY, Leung DY, Lam SW, Li FC, Chiu TY, Chan JC, Chan CH, Poon AS, Yick DW, Chi CC, Lam DS, Lai JS. Ophthalmology; 2008 Dec 05; 115(12):2167-2173.e2. PubMed ID: 18801576 [Abstract] [Full Text] [Related]
14. Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy. Kobayashi H, Kobayashi K. Ophthalmology; 2007 May 05; 114(5):909-14. PubMed ID: 17397924 [Abstract] [Full Text] [Related]
15. Outcomes of Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen Implantation in Primary Advanced Glaucoma. Angmo D, Wadhwani M, Upadhyay AD, Temkar S, Dada T. J Glaucoma; 2017 Jan 05; 26(1):8-14. PubMed ID: 27599174 [Abstract] [Full Text] [Related]
16. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials. Ji Q, Qi B, Liu L, Guo X, Zhong J. J Glaucoma; 2015 Jan 05; 24(5):e88-94. PubMed ID: 25264995 [Abstract] [Full Text] [Related]
17. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma. Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS. Indian J Ophthalmol; 2013 Jul 05; 61(7):338-42. PubMed ID: 23571259 [Abstract] [Full Text] [Related]
18. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Tham CC, Kwong YY, Leung DY, Lam SW, Li FC, Chiu TY, Chan JC, Lam DS, Lai JS. Ophthalmology; 2009 Apr 05; 116(4):725-31, 731.e1-3. PubMed ID: 19243831 [Abstract] [Full Text] [Related]
19. Trabeculectomy with subconjunctival collagen implant in Indian eyes: Long-term results. Singh K, Bhattacharyya M, Mutreja A, Dangda S. Indian J Ophthalmol; 2018 Oct 05; 66(10):1429-1434. PubMed ID: 30249827 [Abstract] [Full Text] [Related]
20. Mitomycin C-augmented Phacotrabeculectomy Versus Phacoemulsification in Primary Angle-closure Glaucoma: A Randomized Controlled Study. El Sayed YM, Elhusseiny AM, Albalkini AS, El Sheikh RH, Osman MA. J Glaucoma; 2019 Oct 05; 28(10):911-915. PubMed ID: 31469675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]